Bisphosphonate Induced Growth Inhibition of Breast Cancer Cells is Augmented by p38 Inhibition
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1026126430905
Reference46 articles.
1. Coleman RE: Skeletal complications of malignancy. Cancer 80(Suppl 8): 1588–1594, 1997
2. Galasko C, Bennett A: Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins. Nature 263: 508–510, 1976
3. Guise TA, Yin JJ, Taylor S, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy G: Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98: 1544–1549, 1996
4. Coleman RE, Purohit OP: Osteoclast inhibition for the treatment of bone metastases. Cancer Treatment Rev 19: 79–103, 1993
5. Kanis JA: Rationale for the use of bisphosphonates in breast cancer. Acta Oncol 35(Suppl 5): 61–67, 1996
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Skeletal Complications;Holland‐Frei Cancer Medicine;2022-10-21
2. Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo;Oncotarget;2016-11-24
3. Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro;Oncology Letters;2014-04-25
4. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion;APMIS;2012-10-22
5. Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?;Journal of Bone Oncology;2012-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3